Form 8-K · Current report
Globe Life 8-K, filed Oct 21, 2026
- Filed
- CIK
- 0000320335
- Accession no.
- 0000320335-26-000224
Summary
Globe Life Inc. reported third quarter 2026 net income of $4.62 per diluted share, down from $4.73 a year earlier, with net operating income of $4.84 per diluted share versus $4.81, and total premium revenue up 7%; the company also repurchased 1.1 million shares for $185 million during the quarter.
Key points
- Book value per share was $85.35, up 23% from the year-ago quarter, and net income as an ROE was 19.7% for the nine months ended September 30, 2026.
- The third quarter included a $120.5 million before-tax remeasurement gain from annual reserve assumption updates, compared with $134.3 million a year earlier.
- Life insurance underwriting margin fell 5% to $458.2 million while health underwriting margin rose 7% to $115.6 million.
- Life net sales were $149.1 million, down 1% from the year-ago quarter.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On October 21, 2026, Globe Life Inc. issued a press release announcing its third quarter 2026 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.